↓ Skip to main content

Dove Medical Press

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy

Overview of attention for article published in Cancer Management and Research, November 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
71 Mendeley
citeulike
1 CiteULike
Title
Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
Published in
Cancer Management and Research, November 2012
DOI 10.2147/cmar.s31070
Pubmed ID
Authors

Daniel L Chan, David L Morris, Archana Rao, Terence C Chua

Abstract

TO REVIEW THE TWO MAIN APPROACHES OF INTRAPERITONEAL (IP) CHEMOTHERAPY DELIVERY IN OVARIAN CANCER: postoperative adjuvant IP chemotherapy after cytoreductive surgery (CRS) and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Canada 1 1%
Unknown 69 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 21%
Student > Master 11 15%
Student > Ph. D. Student 9 13%
Professor > Associate Professor 5 7%
Student > Doctoral Student 4 6%
Other 12 17%
Unknown 15 21%
Readers by discipline Count As %
Medicine and Dentistry 26 37%
Agricultural and Biological Sciences 6 8%
Biochemistry, Genetics and Molecular Biology 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Immunology and Microbiology 2 3%
Other 9 13%
Unknown 19 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2012.
All research outputs
#20,656,161
of 25,374,647 outputs
Outputs from Cancer Management and Research
#1,128
of 2,074 outputs
Outputs of similar age
#158,246
of 202,252 outputs
Outputs of similar age from Cancer Management and Research
#6
of 9 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,074 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 202,252 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.